Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures, 65537-65539 [2012-26471]
Download as PDF
rmajette on DSK2TPTVN1PROD with
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
environments, as well as submerged
cultural history;
(2) Investigating ocean dynamics and
interactions in new places and at new
scales;
(3) Developing new ocean sensors and
systems to increase the pace and
efficiency of ocean exploration; and
(4) Disseminating information to a
broad spectrum of users through formal
and informal education and outreach
programs.
For more information on the Ocean
Exploration Program please visit the
Web sites: https://
Oceanexplorer.noaa.gov and https://
explore.noaa.gov.
This notice solicits applications for
membership on the Ocean Exploration
Advisory Board. The purpose of the
Ocean Exploration Advisory Board (the
Board) is to advise the Under Secretary
of Commerce for Oceans and
Atmosphere (Under Secretary), who is
also the Administrator of the National
Oceanic and Atmospheric
Administration, on matters pertaining to
ocean exploration including: The
identification of priority areas that
warrant exploration; the development
and enhancement of technologies for
exploring the oceans; managing the data
and information; and disseminating the
results. The Board will also provide
advice on the relevance of the program
with regard to the NOAA Strategic Plan,
the National Ocean Policy
Implementation Plan, and other relevant
guidance documents. Authority to
Which the Committee Reports: The
Board will report to the Under
Secretary, as directed by Section 12005
of the Outer Continental Shelf Lands
Act (43 U.S.C. 1331 et seq.) part of the
Omnibus Public Land Management Act
of 2009 (33 U.S.C. 3405). The Board
shall function solely as an advisory
body in accordance with the Federal
Advisory Committee Act (FACA), as
amended, 5 U.S.C. App., with the
exception of section 14.
Description of Duties: The Board
shall:
a. Advise the Under Secretary on all
aspects of ocean exploration including
areas, features, and phenomena that
warrant exploration; and other areas of
program operation, including
development and enhancement of
technologies for exploring the ocean,
managing ocean exploration data and
information, and disseminating the
results to the public, scientists, and
educators;
b. Assist the program in the
development of a 5-year strategic plan
for the fields of ocean, marine, and
Great Lakes science, exploration, and
discovery, as well as making
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
recommendations to NOAA on the
evolution of the plan based on results
and achievements;
c. Annually review the quality and
effectiveness of the proposal review
process established under Section
12003(a)(4); and
d. Provide other assistance and advice
as requested by the Under Secretary.
Points of View: The Board will consist
of approximately ten members
including a Chair and Co-chair,
designated by the Under Secretary in
accordance with FACA requirements.
Consideration will be given to
candidates who are experts in fields
relevant to ocean exploration, including
ocean scientists, engineers and technical
experts, educators, social scientists, and
communications experts. Membership
will be open to all individuals who have
degrees, professional qualifications,
scientific credentials, national
reputations, international reputations,
or relevant experience that will enable
them to provide expert advice
concerning the Ocean Exploration
Program’s roles within the context of
NOAA’s ocean missions and policies.
Members will be appointed for 3-year
terms, renewable once, and serve at the
discretion of the Under Secretary. The
Chair and Co-chair will serve 3-year
terms renewable once. Initial
appointments will include: Four
members serving an initial 3-year term,
three members serving an initial 4-year
term and three members serving an
initial 5-year term. All renewals will be
3-year terms. If a member resigns before
the end of his or her first term, the
vacancy appointment shall be for the
remainder of the unexpired term, and
shall be renewable twice if the
unexpired term is less than one year.
Members will be appointed as special
government employees (SGEs) and will
be subject to the ethical standards
applicable to SGEs. Members are
reimbursed for actual and reasonable
expenses incurred in performing such
duties but will not be reimbursed for
their time.
As a Federal Advisory Committee the
Board’s membership is required to be
balanced in terms of viewpoints
represented and the functions to be
performed as well as including the
interests of geographic regions of the
country and the diverse sectors of our
society.
The Board will meet two times each
year, exclusive of subcommittee, task
force, and working group meetings.
Nominations: Nominations must
provide: (1) The nominee’s full name,
title, institutional affiliation, and
contact information; (2) the nominee’s
area(s) of expertise; and (3) a short
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
65537
description of his/her qualifications
relative to the kinds of advice being
solicited. Inclusion of a (maximum
length 4 pages) resume or curriculum
vitae is recommended, but not required.
Applications: An application is
required to be considered for Board
membership. To apply, submit a current
resume (maximum length 4 pages) as
indicated in the ADDRESSES section that
includes: (1) The applicant’s full name,
title, institutional affiliation, and
contact information (mailing address,
email, telephones, fax); (2) the
nominee’s area(s) of expertise; and (3) a
short description of his/her
qualifications relative to the kinds of
advice being solicited. A cover letter
stating their interest in serving on the
Board and highlighting specific areas of
expertise relevant to the purpose of the
Board is required.
Dated: October 23, 2012.
Jason Donaldson,
Chief Financial Officer/Chief Administrative
Officer, Office of Oceanic and Atmospheric
Research, National Oceanic and Atmospheric
Administration.
[FR Doc. 2012–26512 Filed 10–26–12; 8:45 am]
BILLING CODE 3510–KA–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Requirements for Patent Applications
Containing Nucleotide Sequence and/
or Amino Acid Sequence Disclosures
ACTION:
Proposed collection; comment
request.
The United States Patent and
Trademark Office (USPTO), as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on the continuing information
collection, as required by the Paperwork
Reduction Act of 1995, Public Law 104–
13 (44 U.S.C. 3506(c)(2)(A)).
DATES: Written comments must be
submitted on or before December 28,
2012.
ADDRESSES: You may submit comments
by any of the following methods:
• Email:
InformationCollection@uspto.gov.
Include ‘‘0651–0024 comment’’ in the
subject line of the message.
• Mail: Susan K. Fawcett, Records
Officer, Office of the Chief Information
Officer, United States Patent and
Trademark Office, P.O. Box 1450,
Alexandria, VA 22313–1450.
• Federal Rulemaking Portal: https://
www.regulations.gov.
SUMMARY:
E:\FR\FM\29OCN1.SGM
29OCN1
65538
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Raul Tamayo,
Legal Advisor, Office of Patent Legal
Administration, United States Patent
and Trademark Office, P.O. Box 1450,
Alexandria, VA 22313–1450; by
telephone at 571–272–7728; or by email
to Raul.Tamayo@uspto.gov. Additional
information about this collection is also
available at https://www.reginfo.gov
under ‘‘Information Collection Review.’’
SUPPLEMENTARY INFORMATION:
I. Abstract
Patent applications that contain
nucleotide and/or amino acid sequence
disclosures must include a copy of the
sequence listing in accordance with the
requirements in 37 CFR 1.821–1.825.
The rules of practice require applicants
to submit these sequence listings in a
standard international format that is
consistent with World Intellectual
Property Organization (WIPO) Standard
ST.25 (1998). Applicants may submit
sequence listings for both U.S. and
international patent applications.
The USPTO uses the sequence listings
during the examination process to
determine the patentability of the
associated patent application. Sequence
listings are also disclosed as part of the
published patent application or issued
patent. Sequence listings that are
extremely long (files larger than 600K or
approximately 300 printed pages) are
published only in electronic form and
are available to the public on the
USPTO sequence data Web page
(https://seqdata.uspto.gov) as an ASCII
text file.
The sequence listing required by 37
CFR 1.821(c) for U.S. patent
applications may be submitted on
paper, compact disc (CD), or through
EFS-Web, the USPTO’s online filing
system. Sequence listings for
international applications may be
submitted on paper or through EFS-Web
only, though sequence listings that are
too large to be filed electronically
through EFS-Web may be submitted on
a separate CD. Applicants may use EFSWeb to file a sequence listing online
with a patent application or subsequent
to a previously filed application.
Under 37 CFR 1.821(e)–(f), applicants
must also submit a copy of the sequence
listing in ‘‘computer readable form’’
(CRF) with a statement indicating that
the CRF copy of the sequence listing is
identical to the paper or CD copy
required by 1.821(c). Applicants may
submit the CRF copy of the sequence
listing to the USPTO on CD or other
acceptable media as provided in 37 CFR
1.824. Sequence listings that are
submitted online through EFS-Web in
the proper text format do not require a
separate CRF copy or the associated
statement.
If the CRF sequence listing in a new
application is identical to the CRF
sequence listing of another application
that the applicant already has on file at
the USPTO, 37 CFR 1.821(e) permits the
applicant to refer to the CRF listing in
the other application rather than having
to submit a duplicate copy of the CRF
listing for the new application. In such
a case, the applicant may submit a letter
identifying the application and CRF
sequence listing that is already on file
and stating that the sequence listing
submitted in the new application is
identical to the CRF copy already filed
with the previous application. The
USPTO provides a form, Request for
Transfer of a Computer Readable Form
Under 37 CFR 1.821(e) (PTO/SB/93), in
order to assist customers in submitting
this statement.
This information collection contains
the sequence listings that are submitted
with biotechnology patent applications.
Information pertaining to the filing of
the initial patent application itself is
Item
rmajette on DSK2TPTVN1PROD with
Totals ..................................................................................................
Estimated Total Annual Non-hour
Respondent Cost Burden: $2,542,350.
This collection has annual (non-hour)
costs in the form of fees and postage
costs. The USPTO provides free
software for creating and validating the
13:18 Oct 26, 2012
Jkt 229001
II. Method of Collection
By mail, hand delivery, or
electronically to the USPTO.
III. Data
OMB Number: 0651–0024.
Form Number(s): PTO/SB/93.
Type of Review: Revision of a
currently approved collection.
Affected Public: Individuals or
households; businesses or other forprofits; and not-for-profit institutions.
Estimated Number of Respondents:
25,250 responses per year. The USPTO
estimates that approximately 27% of
these responses will be from small
entities.
Estimated Time per Response: The
USPTO estimates that it will take the
public approximately six minutes (0.10
hours) to six hours (6.0 hours) to gather
the necessary information, prepare the
form or sequence listing, and submit it
to the USPTO.
Estimated Total Annual Respondent
Burden Hours: 138,225 hours.
Estimated Total Annual Respondent
Cost Burden: $22,590,450. The USPTO
estimates that a sequence listing will
take approximately five hours of
paraprofessional time at an estimated
rate of $122 per hour and one hour of
attorney time at $371 per hour, for a
weighted average rate of $163.50 per
hour for preparing a sequence listing.
The USPTO expects that the Request for
Transfer of a CRF will be prepared by
a paraprofessional at an estimated rate
of $122 per hour. Therefore, the USPTO
estimates that the respondent cost
burden for this collection will be
approximately $22,590,450 per year.
Estimated time for response
Sequence Listing in Application (paper) ....................................................
Sequence Listing in Application (CD) ........................................................
Electronic Sequence Listing in Application (EFS-Web) ............................
Request for Transfer of a Computer Readable Form Under 37 CFR
1.821(e) (PTO/SB/93).
VerDate Mar<15>2010
collected under OMB Control Number
0651–0032, and international
applications submitted under the Patent
Cooperation Treaty (PCT) are covered
under OMB Control Number 0651–0021.
6
6
6
6
Frm 00008
Fmt 4703
Estimated
annual burden
hours
hours ............................................
hours ............................................
hours ............................................
minutes .........................................
8,500
500
14,000
2,250
51,000
3,000
84,000
225
..........................................................
25,250
138,225
format of sequence listings prior to
submission.
In accordance with 35 U.S.C.
41(a)(1)(G), the USPTO only charges a
fee for submitting a sequence listing as
part of a U.S. application or as part of
PO 00000
Estimated
annual
responses
Sfmt 4703
an international application entering the
U.S. national stage if the sequence
listing (i) is not filed via EFS-Web or not
filed on an electronic medium in
compliance with §§ 1.52(e) and 1.821(c)
or (e), and (ii) causes the application to
E:\FR\FM\29OCN1.SGM
29OCN1
rmajette on DSK2TPTVN1PROD with
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
exceed 100 pages. (See 37 CFR 1.52(f).)
Under 37 CFR 1.16(s) and 1.492(j) for
U.S. applications and international
applications entering the U.S. national
stage, respectively, if the application,
including the sequence listings filed on
paper or on a non-compliant electronic
medium, exceeds 100 pages, the
application size fee is $320 (or $160 for
small entities) for each additional 50
pages or fraction thereof. The USPTO
estimates that approximately 250
applications from large entities with
long sequence listings filed on paper or
on a non-compliant electronic medium
will incur an average application size
fee of $960, and approximately 200
applications from small entities with
long sequence listings filed on paper or
on a non-compliant electronic medium
will incur an average application size
fee of $480, for a total of $336,000 per
year.
As a Receiving Office, the USPTO
collects the international filing fee for
each international application it
receives. The basic international filing
fee only covers the first 30 pages of the
international application. As a result, a
$16 fee per page is added to the
international filing fee for each page
over 30 pages of an international
application including a sequence listing
filed on paper or in PDF format. No page
fees are triggered by sequence listings
that are submitted via EFS-Web in the
proper text format. The average length
of a sequence listing filed on paper or
in PDF format in an international
application is 150 pages, which would
carry an additional fee of $2,400 if the
international application were already
at least 30 pages long without the
listing. The USPTO estimates that
approximately 900 of the 8,500
sequence listings filed per year on paper
or in PDF format will be for
international applications, for a total of
$2,160,000 per year in page fees.
Therefore, this collection has a total of
$2,496,000 in fees per year.
Customers may incur postage costs
when submitting a sequence listing to
the USPTO by mail. Mailed submissions
may include the sequence listing on
either paper or CD, the CRF copy of the
listing on CD, and a transmittal letter
containing the required identifying
information. The USPTO estimates that
the average postage cost for a paper or
CD sequence listing submission will be
$5.15 and that 9,000 sequence listings
will be mailed to the USPTO per year,
for a total postage cost of $46,350 per
year.
The total annual (non-hour)
respondent cost burden for this
collection in the form of fees and
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
postage costs is estimated to be
$2,542,350 per year.
IV. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, e.g., the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized or
included in the request for OMB
approval of this information collection;
they also will become a matter of public
record.
Dated: October 24, 2012.
Susan K. Fawcett,
Records Officer, USPTO, Office of the Chief
Information Officer.
[FR Doc. 2012–26471 Filed 10–26–12; 8:45 am]
BILLING CODE 3510–16–P
COMMODITY FUTURES TRADING
COMMISSION
Meeting of Global Markets Advisory
Committee
Commodity Futures Trading
Commission (‘‘CFTC’’).
ACTION: Notice.
AGENCY:
The CFTC announces a
meeting of its Global Markets Advisory
Committee (‘‘GMAC’’).
DATES: The meeting will be held on
November 7, 2012, from 9:30 a.m. to
4:30 p.m. Members of the public who
wish to submit written statements in
connection with the meeting should
submit them by October 31, 2012.
ADDRESSES: The meeting will take place
in the Conference Center at the CFTC’s
headquarters, Three Lafayette Centre,
1155 21st Street NW., Washington, DC
20581. Written statements should be
submitted to: Commodity Futures
Trading Commission, Three Lafayette
Centre, 1155 21st Street NW.,
Washington, DC 20581, attention: Office
of the Secretary. Please use the title
‘‘Global Markets Advisory Committee’’
in any written statement you may
submit. Any statements submitted in
connection with the committee meeting
will be made available to the public.
SUMMARY:
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
65539
FOR FURTHER INFORMATION CONTACT:
Kevin Batteh, Commodity Futures
Trading Commission, Three Lafayette
Centre, 1155 21st Street NW.,
Washington, DC 20581, (202) 418–5636.
SUPPLEMENTARY INFORMATION: This
meeting is being held with less than
fifteen days notice so that the
Committee may obtain the important
views of international regulators, futures
industry professionals, and market
participants on cross-border issues
related to OTC derivatives reform
implementation. There will be two
panels: the first comprised of regulators
from around the globe and the second
comprised of the GMAC members.
The meeting will be open to the
public with seating on a first-come, firstserved basis. Members of the public
who wish to listen to the meeting by
telephone may do so by calling a tollfree telephone line to contact to a live,
listen-only audio feed. Call-in
participants should be prepared to
provide their first name, last name and
affiliation. Additionally, a video
recording of the meeting will be
published through a link on the CFTC’s
Web site. The call-in information, along
with any conference and/or access
codes for callers outside of the US will
be posted on the CFTC Web site prior
to the meeting. Domestic callers can dial
866–844–9416 and use the conference
pass code ‘‘CFTC.’’ All written
submissions provided to the CFTC in
any form will also be published on the
Web site of the CFTC.
Authority: 5 U.S.C. app. 2 § 10(a)(2).
Dated: October 24, 2012.
By the Commodity Futures Trading
Commission.
Sauntia S. Warfield,
Assistant Secretary of the Commission.
[FR Doc. 2012–26533 Filed 10–26–12; 8:45 am]
BILLING CODE P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DoD–2012–OS–0132]
Privacy Act of 1974; System of
Records
Office of the Secretary of
Defense, DoD.
ACTION: Notice to Amend a System of
Records.
AGENCY:
The Office of the Secretary of
Defense is amending a system of records
notice in its existing inventory of record
systems subject to the Privacy Act of
1974 (5 U.S.C. 552a), as amended.
SUMMARY:
E:\FR\FM\29OCN1.SGM
29OCN1
Agencies
[Federal Register Volume 77, Number 209 (Monday, October 29, 2012)]
[Notices]
[Pages 65537-65539]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26471]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures
ACTION: Proposed collection; comment request.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office (USPTO), as part
of its continuing effort to reduce paperwork and respondent burden,
invites the general public and other Federal agencies to take this
opportunity to comment on the continuing information collection, as
required by the Paperwork Reduction Act of 1995, Public Law 104-13 (44
U.S.C. 3506(c)(2)(A)).
DATES: Written comments must be submitted on or before December 28,
2012.
ADDRESSES: You may submit comments by any of the following methods:
Email: InformationCollection@uspto.gov. Include ``0651-
0024 comment'' in the subject line of the message.
Mail: Susan K. Fawcett, Records Officer, Office of the
Chief Information Officer, United States Patent and Trademark Office,
P.O. Box 1450, Alexandria, VA 22313-1450.
Federal Rulemaking Portal: https://www.regulations.gov.
[[Page 65538]]
FOR FURTHER INFORMATION CONTACT: Requests for additional information
should be directed to Raul Tamayo, Legal Advisor, Office of Patent
Legal Administration, United States Patent and Trademark Office, P.O.
Box 1450, Alexandria, VA 22313-1450; by telephone at 571-272-7728; or
by email to Raul.Tamayo@uspto.gov. Additional information about this
collection is also available at https://www.reginfo.gov under
``Information Collection Review.''
SUPPLEMENTARY INFORMATION:
I. Abstract
Patent applications that contain nucleotide and/or amino acid
sequence disclosures must include a copy of the sequence listing in
accordance with the requirements in 37 CFR 1.821-1.825. The rules of
practice require applicants to submit these sequence listings in a
standard international format that is consistent with World
Intellectual Property Organization (WIPO) Standard ST.25 (1998).
Applicants may submit sequence listings for both U.S. and international
patent applications.
The USPTO uses the sequence listings during the examination process
to determine the patentability of the associated patent application.
Sequence listings are also disclosed as part of the published patent
application or issued patent. Sequence listings that are extremely long
(files larger than 600K or approximately 300 printed pages) are
published only in electronic form and are available to the public on
the USPTO sequence data Web page (https://seqdata.uspto.gov) as an ASCII
text file.
The sequence listing required by 37 CFR 1.821(c) for U.S. patent
applications may be submitted on paper, compact disc (CD), or through
EFS-Web, the USPTO's online filing system. Sequence listings for
international applications may be submitted on paper or through EFS-Web
only, though sequence listings that are too large to be filed
electronically through EFS-Web may be submitted on a separate CD.
Applicants may use EFS-Web to file a sequence listing online with a
patent application or subsequent to a previously filed application.
Under 37 CFR 1.821(e)-(f), applicants must also submit a copy of
the sequence listing in ``computer readable form'' (CRF) with a
statement indicating that the CRF copy of the sequence listing is
identical to the paper or CD copy required by 1.821(c). Applicants may
submit the CRF copy of the sequence listing to the USPTO on CD or other
acceptable media as provided in 37 CFR 1.824. Sequence listings that
are submitted online through EFS-Web in the proper text format do not
require a separate CRF copy or the associated statement.
If the CRF sequence listing in a new application is identical to
the CRF sequence listing of another application that the applicant
already has on file at the USPTO, 37 CFR 1.821(e) permits the applicant
to refer to the CRF listing in the other application rather than having
to submit a duplicate copy of the CRF listing for the new application.
In such a case, the applicant may submit a letter identifying the
application and CRF sequence listing that is already on file and
stating that the sequence listing submitted in the new application is
identical to the CRF copy already filed with the previous application.
The USPTO provides a form, Request for Transfer of a Computer Readable
Form Under 37 CFR 1.821(e) (PTO/SB/93), in order to assist customers in
submitting this statement.
This information collection contains the sequence listings that are
submitted with biotechnology patent applications. Information
pertaining to the filing of the initial patent application itself is
collected under OMB Control Number 0651-0032, and international
applications submitted under the Patent Cooperation Treaty (PCT) are
covered under OMB Control Number 0651-0021.
II. Method of Collection
By mail, hand delivery, or electronically to the USPTO.
III. Data
OMB Number: 0651-0024.
Form Number(s): PTO/SB/93.
Type of Review: Revision of a currently approved collection.
Affected Public: Individuals or households; businesses or other
for-profits; and not-for-profit institutions.
Estimated Number of Respondents: 25,250 responses per year. The
USPTO estimates that approximately 27% of these responses will be from
small entities.
Estimated Time per Response: The USPTO estimates that it will take
the public approximately six minutes (0.10 hours) to six hours (6.0
hours) to gather the necessary information, prepare the form or
sequence listing, and submit it to the USPTO.
Estimated Total Annual Respondent Burden Hours: 138,225 hours.
Estimated Total Annual Respondent Cost Burden: $22,590,450. The
USPTO estimates that a sequence listing will take approximately five
hours of paraprofessional time at an estimated rate of $122 per hour
and one hour of attorney time at $371 per hour, for a weighted average
rate of $163.50 per hour for preparing a sequence listing. The USPTO
expects that the Request for Transfer of a CRF will be prepared by a
paraprofessional at an estimated rate of $122 per hour. Therefore, the
USPTO estimates that the respondent cost burden for this collection
will be approximately $22,590,450 per year.
----------------------------------------------------------------------------------------------------------------
Estimated Estimated
Item Estimated time for response annual annual burden
responses hours
----------------------------------------------------------------------------------------------------------------
Sequence Listing in Application (paper)....... 6 hours......................... 8,500 51,000
Sequence Listing in Application (CD).......... 6 hours......................... 500 3,000
Electronic Sequence Listing in Application 6 hours......................... 14,000 84,000
(EFS-Web).
Request for Transfer of a Computer Readable 6 minutes....................... 2,250 225
Form Under 37 CFR 1.821(e) (PTO/SB/93).
-----------------------------------------------------------------
Totals.................................... ................................ 25,250 138,225
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Non-hour Respondent Cost Burden: $2,542,350.
This collection has annual (non-hour) costs in the form of fees and
postage costs. The USPTO provides free software for creating and
validating the format of sequence listings prior to submission.
In accordance with 35 U.S.C. 41(a)(1)(G), the USPTO only charges a
fee for submitting a sequence listing as part of a U.S. application or
as part of an international application entering the U.S. national
stage if the sequence listing (i) is not filed via EFS-Web or not filed
on an electronic medium in compliance with Sec. Sec. 1.52(e) and
1.821(c) or (e), and (ii) causes the application to
[[Page 65539]]
exceed 100 pages. (See 37 CFR 1.52(f).) Under 37 CFR 1.16(s) and
1.492(j) for U.S. applications and international applications entering
the U.S. national stage, respectively, if the application, including
the sequence listings filed on paper or on a non-compliant electronic
medium, exceeds 100 pages, the application size fee is $320 (or $160
for small entities) for each additional 50 pages or fraction thereof.
The USPTO estimates that approximately 250 applications from large
entities with long sequence listings filed on paper or on a non-
compliant electronic medium will incur an average application size fee
of $960, and approximately 200 applications from small entities with
long sequence listings filed on paper or on a non-compliant electronic
medium will incur an average application size fee of $480, for a total
of $336,000 per year.
As a Receiving Office, the USPTO collects the international filing
fee for each international application it receives. The basic
international filing fee only covers the first 30 pages of the
international application. As a result, a $16 fee per page is added to
the international filing fee for each page over 30 pages of an
international application including a sequence listing filed on paper
or in PDF format. No page fees are triggered by sequence listings that
are submitted via EFS-Web in the proper text format. The average length
of a sequence listing filed on paper or in PDF format in an
international application is 150 pages, which would carry an additional
fee of $2,400 if the international application were already at least 30
pages long without the listing. The USPTO estimates that approximately
900 of the 8,500 sequence listings filed per year on paper or in PDF
format will be for international applications, for a total of
$2,160,000 per year in page fees. Therefore, this collection has a
total of $2,496,000 in fees per year.
Customers may incur postage costs when submitting a sequence
listing to the USPTO by mail. Mailed submissions may include the
sequence listing on either paper or CD, the CRF copy of the listing on
CD, and a transmittal letter containing the required identifying
information. The USPTO estimates that the average postage cost for a
paper or CD sequence listing submission will be $5.15 and that 9,000
sequence listings will be mailed to the USPTO per year, for a total
postage cost of $46,350 per year.
The total annual (non-hour) respondent cost burden for this
collection in the form of fees and postage costs is estimated to be
$2,542,350 per year.
IV. Request for Comments
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden
(including hours and cost) of the proposed collection of information;
(c) ways to enhance the quality, utility, and clarity of the
information to be collected; and (d) ways to minimize the burden of the
collection of information on respondents, e.g., the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized or
included in the request for OMB approval of this information
collection; they also will become a matter of public record.
Dated: October 24, 2012.
Susan K. Fawcett,
Records Officer, USPTO, Office of the Chief Information Officer.
[FR Doc. 2012-26471 Filed 10-26-12; 8:45 am]
BILLING CODE 3510-16-P